Sitting down might seem harmless, but for heart attack survivors, prolonged…
Category: Therapeutic Areas
Home /
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital…
Prion diseases are rapidly progressive, neurodegenerative disorders caused by infectious protein…
A routine kidney transplant took a tragic turn when a Michigan…
Black-legged ticks are known for carrying bacterial diseases, including Lyme disease….
Low back pain affects almost everyone at some point during their…
The highly pathogenic H5N1 virus, also known as avian flu or…
People with a rare genetic form of Alzheimer’s disease can begin…
Cruise ships are seeing a surge in norovirus outbreaks this year….
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming…
With millions of tuberculosis (TB) cases left undiagnosed each year due…
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom),…
Eli Lilly has launched a new way for patients to access…
Clinical trial results show that pembrolizumab, an immunotherapy drug used to…
United States agricultural hubs are currently facing an unprecedented outbreak of…
In the early days of the human immunodeficiency virus (HIV) epidemic,…
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in…
The Danish pharmaceutical company Novo Nordisk has announced promising early results…
Death rates for cancer are lower than ever, having declined as…
The relationship between cancer and the nervous system has been a…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
Webinars
Less Sitting, More Living: How Activity Reduces Risk for Heart Attack Survivors
June 24, 2025
Sitting down might seem harmless, but for heart attack survivors, prolonged sedentary time could spell significant trouble. According to recent research, replacing just 30 minutes
Unanswered Questions: Mysterious Cluster of Brain Tumors Investigated at Massachusetts Hospital
June 2, 2025
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital in Massachusetts have been diagnosed with benign brain tumors, sparking concern about a cancer
Creutzfeldt-Jakob Disease Outbreak Sparks Concern
May 21, 2025
Prion diseases are rapidly progressive, neurodegenerative disorders caused by infectious protein particles called prions. While these diseases can affect both humans and animals, they are
Silent Infection: The Rare Risk of Rabies Transmission from Organ Transplantation
May 12, 2025
A routine kidney transplant took a tragic turn when a Michigan resident died as a result of contracting rabies from the donated organ. This event
Ticked Off: The Hidden Risk of Red Meat Allergy from Tick Bites
May 5, 2025
Black-legged ticks are known for carrying bacterial diseases, including Lyme disease. New research suggests that their bite can also trigger alpha-gal syndrome (AGS), also known
Backed Into a Corner: Few Interventions Work for Low Back Pain
April 28, 2025
Low back pain affects almost everyone at some point during their lifetime. Globally, it is the leading cause of years lived with disability, a measure
There’s a New Bird Flu in Town
April 23, 2025
The highly pathogenic H5N1 virus, also known as avian flu or bird flu, continues to sweep through poultry farms in the United States. While consumers
Slowing the Clock: Trial Delivers Hope in Delaying Alzheimer’s Disease
April 7, 2025
People with a rare genetic form of Alzheimer’s disease can begin to experience memory loss and dementia starting in their 30s, 40s and 50s. Although
Rough Seas: Norovirus Outbreaks Surge on Cruise Ships and Beyond
March 17, 2025
Cruise ships are seeing a surge in norovirus outbreaks this year. The Centers for Disease Control and Prevention (CDC), which publishes details of the outbreaks
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and strips
Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
November 11, 2024
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence (AI)
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to advanced
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials at
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal cancer
Experts Assess Risk of Avian Flu to Humans
July 29, 2024
United States agricultural hubs are currently facing an unprecedented outbreak of the H5N1 virus, more commonly known as the avian flu or “bird flu.” As
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making people
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk of
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to outperform
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in oncology
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the early
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
